People: Volcano Corp (VOLC.OQ)

VOLC.OQ on NASDAQ Stock Exchange Global Select Market

20.47USD
2 Aug 2013
Price Change (% chg)

$-0.01 (-0.05%)
Prev Close
$20.48
Open
$20.51
Day's High
$20.57
Day's Low
$20.37
Volume
15,761
Avg. Vol
238,208
52-wk High
$30.15
52-wk Low
$16.37

Search Stocks

Summary

Name Age Since Current Position

Ronald Matricaria

70 2009 Chairman of the Board, Lead Independent Director

R. Scott Huennekens

48 2002 President, Chief Executive Officer, Director

John Dahldorf

56 2011 Chief Financial Officer

Dale Flanders

2010 President - Axsun Division

Michele Perrino

42 2012 President, Europe, Africa, Middle East, and India Operations

Jorge Quinoy

59 2012 President - U.S. & APLAC Commercial Sales

David Sheehan

50 2012 Chief Operating Officer

Darin Lippoldt

47 2013 Executive Vice President, Chief Compliance Officer, General Counsel, Secretary

John Onopchenko

53 2013 Executive Vice President - Strategy, Business Development and Integration

Kieran Gallahue

49 2007 Independent Director

Lesley Howe

68 2005 Independent Director

Siddhartha Kadia

43 2013 Independent Director

Alexis Lukianov

57 2007 Independent Director

Leslie Norwalk

47 2011 Independent Director

Roy Tanaka

65 2009 Independent Director

Eric Topol

58 2011 Independent Director

Neal Rosen

IR Contact

Biographies

Name Description

Ronald Matricaria

Mr. Ronald A. Matricaria is Chairman of the Board, Lead Independent Director of Volcano Corporation. He has over 35 years of medical device and pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and Company, Inc. From April 1993 to May 1999, he served as President and Chief Executive Officer of St. Jude Medical, Inc. and served as Chairman of the Board of Directors from January 1995 to December 2002. Prior to joining St. Jude Medical, Mr. Matricaria spent 23 years with Eli Lilly and Company, Inc. His last position was Executive Vice President of the Pharmaceutical Division of Eli Lilly and Company and President of its North American operations. He also served as President of Eli Lilly International Corporation, as well as President of its Medical Device Division. Mr. Matricaria currently serves on the boards of Life Technologies Corporation, a life sciences company, and Phoenix Children's Hospital. He previously served as Chairman of the Board of Directors for Kinetic Concepts, Inc, a medical technology company. Mr. Matricaria holds a bachelor's degree in pharmacy from the Massachusetts College of Pharmacy and was awarded an honorary Doctor of Science degree in pharmacy, as well as an honorary PharmD degree, in recognition of his contributions to the practice of pharmacy.

R. Scott Huennekens

Mr. R. Scott Huennekens is President, Chief Executive Officer, Director of Volcano Corporation, since April 2002. From January 2000 to March 2002, Mr. Huennekens served as the President and Chief Executive Officer of Digirad Corporation, a medical imaging company. Mr. Huennekens holds a B.S. in Business Administration from the University of Southern California and an M.B.A. from Harvard Business School.

John Dahldorf

Mr. John T. Dahldorf is Chief Financial Officer of Volcano Corporation, since July 2003. From March 2002 to December 2002, Mr. Dahldorf served as Co-Chief Executive Officer of Digirad Corporation, a medical imaging company, where he also served as the Chief Financial Officer from November 2001 to December 2002. From March 1999 to November 2001, Mr. Dahldorf served as the Finance Director of Arrow Electronics, Inc., a distributor of electronic components and computer products. Mr. Dahldorf holds a B.B. in Finance and an M.B.A. from Western Illinois University.

Dale Flanders

Dr. Dale C. Flanders, Ph.D., is President - Axsun Division of Volcano Corp. He has served as the President of Axsun Division since December 2008. Prior to that, Dr. Flanders founded Axsun Technologies, Inc. in 1998 and served as its Chief Executive Officer and Chief Technology Officer until it was acquired by the company in 2008. Prior to founding Axsun, Dr. Flanders served as the Vice President of Engineering and Chief Technology Officer for Lasertron, Inc., a pioneer in developing and manufacturing laser and non-laser light sources, from 1994 to 1998. Dr. Flanders holds a B.S., an M.S. and a Ph.D. in Electrical Engineering from Massachusetts Institute of Technology and is listed as the inventor on more than 75 patents.

Michele Perrino

Mr. Michele Perrino is President, Europe, Africa, Middle East, and India Operations of Volcano Corp., since October 2012. Prior to this role, Mr. Perrino was Vice President and General Manager for EMEAI. Before joining Volcano in June 2007 as Country Manager for Italy, he held management positions for Ethicon Endo Surgery and Cordis, divisions of Johnson & Johnson, Inc., based in Italy. Mr. Perrino received a Master degree in Economics from the University of Bari (Italy) and Santander (Spain), and a Post-graduate Degree in Finance.

Jorge Quinoy

Mr. Jorge J. Quinoy is President - U.S. & APLAC Commercial Sales of Volcano Corp., since October 1, 2012. Prior to that time, Mr. Quinoy served as Executive Vice President, Global Sales, since December 2008. From July 2003 to December 2008, Mr. Quinoy served as Vice President of Global Sales. From August 2001 to July 2003, Mr. Quinoy served as the Vice President of Sales for Jomed, Inc., a medical technology company. From January 2001 to August 2001, Mr. Quinoy served as the Vice President of Sales for Altiva Corporation, a medical technology company. From 1999 to 2000, Mr. Quinoy served as Vice President of Sales for Medtronic AVE, Inc. Mr. Quinoy holds a B.S. in Public Relations and Marketing from the University of Florida.

David Sheehan

Mr. David M. Sheehan is Chief Operating Officer of Volcano Corp., since February 2012. Prior to that, Mr. Sheehan was President of the IVUS & FM Business Units since March 2010. From June 2008 to March 2010, Mr. Sheehan served as Executive Vice President. Prior to joining the Company, from April 2005 to May 2008, he was a consultant and Chief Executive Officer for various start-up companies including Petritech, Inc., a materials company, and VOZ Sports, Inc., a communications company. From March 2002 to April 2005 he served as the President and Chief Executive Officer of Digirad Corporation, a maker of cardiac imaging equipment and from September 2000 to March 2005, the President of Digirad Imaging Solutions, Inc., a wholly owned subsidiary of Digirad Corporation. From May 1999 to September 2000, Mr. Sheehan served as the President and Chief Executive Officer of Rapidcare.com, an e-healthcare company. From May 1997 to May 1999, Mr. Sheehan served as Vice President of Sales & Marketing for a division of Baxter Healthcare Corporation which provided cardiopulmonary services to hospitals. From July 1991 to May 1997, Mr. Sheehan worked at Haemonetics Corporation, a supplier of blood processing services and equipment, in various sales, marketing and business development positions. Mr. Sheehan received a B.S. in mechanical engineering from Worcester Polytechnic Institute and an M.B.A. from the Tuck School of Business at Dartmouth College.

Darin Lippoldt

Mr. Darin M. Lippoldt is Executive Vice President, Chief Compliance Officer, General Counsel, Secretary of Volcano Corp. He has served as Executive Vice President and General Counsel since January 2013. Prior to that time, he served as Senior Vice President and General Counsel since August 2010. Mr. Lippoldt has also served as Secretary since July 2011 and Chief Compliance Officer since October 2011. From November 2003 until he joined the Company, Mr. Lippoldt served as Associate General Counsel at Amylin Pharmaceuticals, a pharmaceutical company. He previously practiced corporate and securities law with the law firms of Fulbright & Jaworski LLP and Matthews and Branscomb, P.C. Mr. Lippoldt holds a B.B.A. in Finance, an M.A. in International Relations and a J.D. from St. Mary's University.

John Onopchenko

Mr. John Onopchenko is Executive Vice President - Strategy, Business Development and Integration of Volcano Corp. He is a founder and Managing Director of Synergy Life Science Partners, L.P., a venture capital firm. From 2000 to 2006, Mr. Onopchenko was Vice President, Venture Investments, with Johnson & Johnson Development Corporation, and served as a member of the Board of Directors from 2002 to 2006. From 1996 to 1999, he served as Vice President and a member of the Board of Directors of Advanced Sterilization Products, a division of Johnson & Johnson. Mr. Onopchenko served on the boards of directors of various private companies in the healthcare and life sciences industry. Mr. Onopchenko holds a masters degree in Business from the University of Chicago, Graduate School of Business and a B.S. from Ursinus College.

Kieran Gallahue

Mr. Kieran T. Gallahue is Independent Director of Volcano Corporation, since July 2007. Since February 2011, Mr. Gallahue has served as Chairman and Chief Executive Officer of CareFusion Corporation, a publicly-traded, global medical technology company. From January 2008 to February 2011, Mr. Gallahue served as Chief Executive Officer and a director of ResMed Inc., a publicly-traded developer, manufacturer and marketer of products for the treatment of sleep-disordered breathing and other respiratory disorders. From September 2004 to February 2011, Mr. Gallahue also served as President (ResMed Global) of ResMed Inc. From January 2003 to September 2004, Mr. Gallahue served as President and Chief Operating Officer (ResMed Americas) of ResMed Inc. From 1997 to 2003, Mr. Gallahue served in various capacities with Nanogen, Inc., a DNA research and medical diagnostics company, including as President, Chief Financial Officer and Vice President of Strategic Marketing. Prior to 1997, he held a variety of sales, marketing and financial roles at Instrumentation Laboratory, Procter & Gamble and the General Electric Company. Mr. Gallahue holds a B.S. from Rutgers University and an M.B.A. from Harvard Business School.

Lesley Howe

Mr. Lesley H. Howe is Independent Director of Volcano Corporation, since October 2005. From December 2001 until May 2007, he served as Chief Executive Officer at Consumer Networks LLC, an Internet marketing and promotions company. Mr. Howe currently serves on the boards of directors of Jamba, Inc., an owner and operator of fresh juice and smoothie retail stores, and NuVasive, Inc., a medical technology company. He previously served on the board of directors of P.F. Chang's China Bistro, Inc. From July 1967 to September 1997, Mr. Howe held several positions at KPMG LLP, an international auditing and accounting firm, and served as Area Managing Partner/Managing Partner of their Los Angeles office from May 1994 to September 1997. Mr. Howe holds a B.S. in Accounting from the University of Arkansas and is a certified public accountant (inactive).

Siddhartha Kadia

Dr. Siddhartha Kadia, Ph.D., is Independent Director of Volcano Corporation, since March 2013. Since April 2011, Dr, Kadia has served as President of Life Technologies Greater China, a subsidiary of Life Technologies Corporation, a publicly-traded global biotechnology company. From April 2010 to April 2011 Dr. Kadia served as the President of Life Technologies Japan Ltd., and prior to that, served in other roles within Life Technologies, including Chief Operating Officer of Life Technologies Japan Ltd, a position he held from June 2009 to March 2010, and as Chief Marketing Officer, a position he held from July 2008 to June 2009. From July 2005 to July 2008, he served in numerous roles at Invitrogen Corporation, a publicly-traded biotechnology company that was merged with Applied Biosystems Inc. in 2008 to form Life Technologies, including most recently as Corporate Vice President, Global Marketing and eBusiness, a position he served in from June 2007 until July 2008. Before joining Invitrogen Corporation in 2005, Dr. Kadia served as an Engagement Manager and Senior Associate at McKinsey & Company and, prior to McKinsey, was a post doctoral fellow at Johns Hopkins University School of Medicine. Dr. Siddhartha grew up in India and has lived and worked in the US, Europe, Japan and China. Dr. Siddhartha holds a Ph.D. in Biomedical Engineering from Johns Hopkins University, a Master's in Biomedical Engineering from Rutgers University and a B.E. in Electronics and Telecommunications from Gujarat University in India.

Alexis Lukianov

Mr. Alexis V. Lukianov is Independent Director of Volcano Corporation, since December 2007. Since July 1999, Mr. Lukianov has served NuVasive, Inc. as its President, Chief Executive Officer and a director and, since February 2004, Mr. Lukianov has served as Chairman of the Board of Directors and Chief Executive Officer of NuVasive, Inc. NuVasive, Inc. is a publicly-traded medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. From April 1996 to April 1997, Mr. Lukianov was a founder of, and served as Chairman of the Board of Directors and Chief Executive Officer of, BackCare Group, Inc., a spine physician practice management company. From January 1990 to October 1995, Mr. Lukianov held a variety of senior executive positions, including President, with Medtronic Sofamor Danek, Inc., a developer and manufacturer of medical devices to treat disorders of the cranium and spine and a subsidiary of Medtronic, Inc., a publicly-traded medical technology company. Mr. Lukianov also serves on the boards of BIOCOM, Medical Device Manufacturers Association and Ophthonix, Inc., a privately-held company focused on vision correction technology.

Leslie Norwalk

Ms. Leslie V. Norwalk, Esq., is Independent Director of Volcano Corporation, since October 2011. Since 2007, she has served as Strategic Counsel to Epstein Becker & Green, P.C., a law firm, and two consulting agencies: EBG Advisors and National Health Advisors. She also is a principal in Norwalk & Associates, a law firm. Ms. Norwalk serves as an advisor to three private equity firms-Warburg Pincus, Ferrer Freeman & Company and Enhanced Equity Fund-and sits on the boards of directors of multiple private entities. Ms. Norwalk served the George W. Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS), where she managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, the survey and certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency's Deputy Administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit. Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C., where she advised clients on a variety of health policy matters. She also served in the first Bush Administration in the White House Office of Presidential Personnel and the Office of the U.S. Trade Representative. Ms. Norwalk earned a J.D. degree from the George Mason University School of Law and a bachelor's degree in economics and international relations from Wellesley College.

Roy Tanaka

Mr. Roy T. Tanaka is Independent Director of Volcano Corporation, since April 2009. From 2004 through 2008, Mr. Tanaka served as the Worldwide President of Biosense Webster, Inc. for Johnson & Johnson. Mr. Tanaka joined Johnson & Johnson as the U.S. President of Biosense Webster, Inc. in 1997. From 1992 to 1997, he served in a variety of senior management positions at Sorin Biomedical, Inc., including President and Chief Executive Officer. From 1989 to 1992, Mr. Tanaka served in vice president roles with Shiley, a division of Pfizer, Inc. Mr. Tanaka was formerly a director of Tomotherapy, Inc., a publicly traded medical device company. Mr. Tanaka received a B.S. in Mechanical Engineering from Purdue University and an M.B.A. from Illinois Benedictine College.

Eric Topol

Dr. Eric J. Topol, M.D., is Independent Director of Volcano Corporation, since October 2011. Since January 2007, Dr. Topol has served as the Director of the Scripps Translational Science Institute, a National Institutes of Health funded program of the Clinical and Translational Science Award Consortium. He is Professor of Genomics at the Scripps Research Institute, the Chief Academic Officer of Scripps Health and a senior consulting cardiologist at Scripps Clinic. Prior to Scripps, Dr. Topol served on the faculty of Case Western as a professor in genetics, chaired the Department of Cardiovascular Medicine at Cleveland Clinic for 15 years and founded the Cleveland Clinic Lerner College of Medicine. Dr. Topol formerly served on the Scientific Advisory Board of Cardionet, Inc., and currently serves on the board of directors of DexCom, Inc., a wireless health technology company, and Sotera Wireless, Inc., a privately held company. Dr. Topol holds a B.A. from the University of Virginia and an M.D. from the University of Rochester.

Neal Rosen

Options Compensation

Search Stocks